Most Recent
Construction PRO
No early discovery for likely recovery in $350M suit against Probuild
The owners of the Werribee shopping centre in Victoria have lost their bid for preliminary discovery related to the likely recovery in their $356 million claim against builder Probuild. 
Chartered Accountants drops investigation into ex-PwC tax partner
Accounting disciplinary body Chartered Accountants ANZ has dropped its investigation into former PwC tax partner Wayne Plummer, who was linked to the firm's tax leaks scandal in 2023. 
Virbac loses bid to block generic animal drug
Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories. 
New Zealand’s highest court endorses early common fund orders
ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
IP firm loses challenge to Apple’s authentication patent
An intellectual property firm has lost its legal challenge to Apple's bid to patent its method of authentication on electronic devices, including smartphones.
Law firm can’t dodge $5.4M security in Macquarie class action
Maurice Blackburn is stuck paying $5.4 million in security in a flex commissions class action against Macquarie, with a judge saying it represents a “business risk willingly undertaken”.
Top 10 class action settlements of 2024
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Toyota unit Hino to pay $87M to settle emissions cheating class action
Hino Motors has agreed to pay $87 million to settle a consumer class action alleging it misrepresented that its vehicles met Australian emissions and road standards over a 20-year period.
‘Considerable disquiet’: Pelvic mesh group members can challenge $405M settlements
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.